Jang, Hyemin

O -GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosis

Park, J., Ha, H.-J., Chung, E. S., Baek, S. H., Cho, Y., Kim, H. K., Han, J., Sul, J. H., Lee, J., Kim, E., et al. (2021) · Science Advances

Glycosylation and Glycoproteins ResearchAlzheimer's disease research and treatments

Cited by 139

Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer

Ha, D.-H., Min, A., Kim, S., Jang, H., Kim, S. H., Kim, H.-J., Ryu, H. S., Ku, J.-L., Lee, K.-H., & Im, S.-A. (2020) · Scientific Reports

PARP inhibition in cancer therapyDNA Repair Mechanisms

Cited by 78

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers

Jang, H., Park, J., Woo, S., Kim, S., Kim, H. J., Na, D. L., Lockhart, S. N., Kim, Y., Kim, K. W., Cho, S. H., et al. (2019) · NeuroImage Clinical

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 46

Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models

Song, H.-L., Kim, N.-Y., Park, J., Kim, M. I., Jeon, Y.-N., Lee, S.-J., Cho, K., Shim, Y.-L., Lee, K.-H., Mun, Y.-S., et al. (2023) · Journal of Clinical Investigation

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 26

Shared genetic architectures of educational attainment in East Asian and European populations

Chen, T.-T., Kim, J., Lam, M., Chuang, Y.-F., Chiu, Y.-L., Lin, S.-C., Jung, S.-H., Kim, B., Kim, S., Cho, C., et al. (2024) · Nature Human Behaviour

Genetic Associations and EpidemiologyCognitive Abilities and Testing

Cited by 18